• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RUBICON 18; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RUBICON 18; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 39540
Medical Device Problem Codes Break (1069); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/26/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that catheter break occurred and detached piece was removed through snaring.The more than 80% stenosed target lesion was located in the moderately tortuous and severely calcified vessel of the left lower extremity.A 150cm rubicon 18 catheter guide was selected for use in a left leg extremity arteriogram.During the procedure, the rubicon was advanced past the guidewire and resistance was met.Upon pulling back, the catheter was kinked.Rubicon catheter was tugged, and it was noted that the catheter detached at the second radiopaque (ro) marker.The remainder of the catheter was removed, and the detached piece was successfully retrieved using a non-boston scientific (bsc) snare kit.The procedure was completed with another of the same device without further issues.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the device was returned for evaluation.The device was examined visually, and it was found that the tip section of the device was detached at approximately 154cm from the hub.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that catheter break occurred and detached piece was removed through snaring.The more than 80% stenosed target lesion was located in the moderately tortuous and severely calcified vessel of the left lower extremity.A 150cm rubicon 18 catheter guide was selected for use in a left leg extremity arteriogram.During the procedure, the rubicon was advanced past the guidewire and resistance was met.Upon pulling back, the catheter was kinked.Rubicon catheter was tugged, and it was noted that the catheter detached at the second radiopaque (ro) marker.The remainder of the catheter was removed, and the detached piece was successfully retrieved using a non-boston scientific (bsc) snare kit.The procedure was completed with another of the same device without further issues.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBICON 18
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19130526
Report Number2124215-2024-19828
Device Sequence Number14617143
Product Code DQY
UDI-Device Identifier08714729829256
UDI-Public08714729829256
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K122394
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number39540
Device Catalogue Number39540
Device Lot Number0033516317
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/26/2024
Supplement Date Received by Manufacturer04/29/2024
Initial Report FDA Received Date04/18/2024
Supplement Report FDA Received Date05/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexMale
Patient RaceBlack Or African American
-
-